| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30,115 |
28,300 |
$8.53M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,467 |
18,168 |
$999K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,073 |
2,852 |
$856K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,524 |
9,894 |
$499K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,218 |
5,917 |
$395K |
| 80053 |
Comprehensive metabolic panel |
15,119 |
13,188 |
$233K |
| 71045 |
Radiologic examination, chest; single view |
5,005 |
4,558 |
$154K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,430 |
14,148 |
$152K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,526 |
4,833 |
$147K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
783 |
708 |
$127K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
924 |
851 |
$112K |
| 71046 |
Radiologic examination, chest; 2 views |
2,030 |
1,925 |
$108K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
202 |
195 |
$108K |
| 81025 |
|
8,145 |
7,466 |
$81K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,067 |
1,018 |
$62K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,846 |
3,667 |
$58K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,522 |
1,431 |
$56K |
| 81001 |
|
9,644 |
8,739 |
$50K |
| 76801 |
|
623 |
532 |
$50K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,080 |
1,001 |
$49K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
648 |
543 |
$43K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
726 |
562 |
$43K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,041 |
2,859 |
$37K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
942 |
913 |
$31K |
| 36415 |
Collection of venous blood by venipuncture |
19,896 |
17,546 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,049 |
1,004 |
$20K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
285 |
253 |
$19K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
263 |
245 |
$19K |
| 84484 |
|
3,218 |
2,675 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
565 |
529 |
$14K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
565 |
529 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
722 |
615 |
$14K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
349 |
331 |
$12K |
| 83880 |
|
1,175 |
999 |
$12K |
| 84702 |
|
1,302 |
1,065 |
$11K |
| 87486 |
|
202 |
195 |
$10K |
| 87581 |
|
202 |
195 |
$10K |
| 83690 |
|
2,715 |
2,422 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
202 |
195 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
427 |
370 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,093 |
900 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,042 |
981 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
838 |
741 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,903 |
3,073 |
$4K |
| G0378 |
Hospital observation service, per hour |
55 |
25 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,256 |
1,070 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
44 |
40 |
$3K |
| 85027 |
|
844 |
728 |
$3K |
| 81003 |
|
1,709 |
1,561 |
$3K |
| 87210 |
|
596 |
565 |
$3K |
| 85730 |
|
1,252 |
1,138 |
$2K |
| 76830 |
Ultrasound, transvaginal |
27 |
25 |
$2K |
| 83735 |
|
985 |
836 |
$2K |
| 85610 |
|
1,464 |
1,319 |
$2K |
| 86900 |
|
959 |
845 |
$2K |
| 83605 |
|
452 |
380 |
$2K |
| 86901 |
|
915 |
844 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
935 |
769 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
702 |
572 |
$1K |
| 82330 |
|
975 |
706 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,192 |
962 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
111 |
102 |
$878.19 |
| 84703 |
|
170 |
157 |
$869.40 |
| 85007 |
|
387 |
340 |
$846.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,023 |
2,534 |
$613.38 |
| 84030 |
|
89 |
75 |
$609.56 |
| 94760 |
|
71 |
60 |
$539.21 |
| 84132 |
|
1,064 |
783 |
$536.45 |
| 86850 |
|
72 |
69 |
$477.64 |
| 84145 |
|
40 |
39 |
$466.23 |
| 74018 |
|
17 |
17 |
$452.23 |
| 87040 |
|
64 |
54 |
$446.47 |
| 73630 |
|
30 |
28 |
$444.36 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
15 |
13 |
$424.98 |
| 73030 |
|
27 |
25 |
$420.97 |
| 82565 |
|
1,008 |
734 |
$390.01 |
| 82947 |
|
962 |
692 |
$389.81 |
| 84295 |
|
899 |
652 |
$322.43 |
| 85014 |
|
848 |
640 |
$307.15 |
| 82435 |
|
920 |
658 |
$298.12 |
| 84520 |
|
876 |
647 |
$270.37 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
463 |
400 |
$270.22 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
27 |
24 |
$240.26 |
| T2101 |
Human breast milk processing, storage and distribution only |
23 |
12 |
$238.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
398 |
276 |
$208.78 |
| 82948 |
|
33 |
15 |
$168.82 |
| 86140 |
|
78 |
67 |
$155.00 |
| 96376 |
|
22 |
14 |
$145.50 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
55 |
41 |
$137.44 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
344 |
324 |
$131.41 |
| 85379 |
|
27 |
27 |
$117.81 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$54.07 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
70 |
62 |
$42.87 |
| 82962 |
|
1,790 |
1,150 |
$33.54 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
402 |
267 |
$23.86 |
| 87186 |
|
20 |
17 |
$20.73 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
12 |
12 |
$9.03 |
| J2060 |
Injection, lorazepam, 2 mg |
27 |
25 |
$9.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
32 |
30 |
$1.11 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
114 |
87 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| 36416 |
|
16 |
14 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
30 |
26 |
$0.00 |
| 80047 |
|
21 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,988 |
1,490 |
$0.00 |